Rising cases of infectious
diseases and established healthcare sector is fuelling to the growth of
antibiotics and corticosteroids market in North America
Regional segmentation of Antibiotics
and Corticosteroids Market by Coherent Market Insights comprises of North
America, Latin America, Europe, Asia Pacific, the Middle East and Africa. North
America hold the major share in the antibiotics and corticosteroids market due
to the high prevalence rate of respiratory syncytial virus (RSV) infection and
the need of antibiotic and corticosteroids treatment of such diseases. For
instance, the data given by Centers for Disease Control and Prevention (CDC),
around 2.1 million children are diagnosed with RSV and 14, 000 adult population
die due to this disease annually. Latin America also hold the large share in
the antibiotics and corticosteroids market followed by Asia Pacific due to the
progress in pharmaceutical industry.
Antibiotics are used to terminate
the bacterial growth or bacteria itself in the case of bacterial infection,
whereas, corticosteroids are used to treat the allergy and inflammatory
condition. There are some functions which corticosteroids can perform while
antibiotics cannot perform and vice-versa. At times, the physician prescribes
the dose of antibiotics in addition with corticosteroids so that antibiotic
will help attack the microorganism cell wall whereas the inflammatory process
can be tackled by the corticosteroids. Corticosteroids also decreases the pain
related to inflammation by inhibiting chemical mediators. Over dosage or misuse
of both compounds might lead to adverse
effects such as failure of immune system.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/781
Efficacy of combine treatment of
antibiotics and corticosteroids on several chronic diseases is the major factor
for growth of antibiotics and corticosteroids market
The use of antibiotics with the
combination of corticosteroids has proven effective in the treatment of human
respiratory syncytial virus (hRSV) infection, Cepacia syndrome, S. Aureus
arthritis, pneumonia, Zika Virus, and Ebola. According to the data published in
Journal of Tropical Diseases and Public Health, in 2016, around 6.3 million
children died in 2013, wherein 51.8% died due to infectious diseases and
largest was accounted due to pneumonia for around 935,000 deaths. However,
around 3.4 million children are infected with the human Respiratory syncytial
virus (RSV) which is associated to acute lower respiratory infections (ALRI).
Supportive government activities in the favor of antibiotics and
corticosteroids production is helping to boost the antibiotic and
corticosteroids market. For instance, introduction of Antibiotics Incentives
Now (GAIN) act which has the provisions to facilitate the development of
therapy against antigen resistant pathogens is expected to propel the approval
for antibiotics.
However, some of the restraints
which are likely to hamper the growth of antibiotics and corticosteroids market
include the adverse effect on high intake or misuse of both antibiotics and
corticosteroids, use in animals which are later consumed by humans, and
regulations and policies on use of antibiotics and corticosteroids.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/antibiotics-and-corticosteroids-market-781
Rise in population with pneumonia
is contributing to the growth of this disease segment in antibiotics and
corticosteroids market
Industry players are involved in
the regional expansion and collaborations with other companies to hold the
larger share in the antibiotics and corticosteroids market
Key industry players operating
the global antibiotics and corticosteroids market include Novartis, Pfizer,
GlaxoSmithKline (GSK), Abbott Laboratories, Sanofi, Johnson & Johnson,
Merck, Sumitomo, AstraZeneca, Cipla, and Astellas Pharma. The generic drug
manufacturers are dominating in the antibiotics and corticosteroid market due
to the presence of key drugs that are helping to generate the revenue with
availability of few patent products. Adoption
of various strategies such as regional expansion, novel product
development, collaborations, and partnerships by the industry players to hold
the major share in the antibiotics and corticosteroids market. For instance,
Pfizer made an agreement with AstraZeneca in 2016, which has helped to acquire
the commercialization and development right to the Pfizer’s business mostly
outside the U.S.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/781
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment